rs143129413
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_024824.5(ZC3H14):c.1432G>A(p.Val478Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024824.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC3H14 | NM_024824.5 | c.1432G>A | p.Val478Ile | missense_variant | 11/17 | ENST00000251038.10 | NP_079100.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC3H14 | ENST00000251038.10 | c.1432G>A | p.Val478Ile | missense_variant | 11/17 | 1 | NM_024824.5 | ENSP00000251038.5 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000505 AC: 127AN: 251364Hom.: 0 AF XY: 0.000493 AC XY: 67AN XY: 135852
GnomAD4 exome AF: 0.000315 AC: 461AN: 1461854Hom.: 1 Cov.: 31 AF XY: 0.000307 AC XY: 223AN XY: 727236
GnomAD4 genome AF: 0.000289 AC: 44AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 21, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at